- Home
- LIMN vs CPAC Comparison
LIMN vs CPAC Comparison
Compare LIMN & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIMN
- CPAC
- Stock Information
- Founded
- LIMN 2018
- CPAC 1949
- Country
- LIMN United States
- CPAC Peru
- Employees
- LIMN N/A
- CPAC 1976
- Industry
- LIMN
- CPAC Building Materials
- Sector
- LIMN
- CPAC Industrials
- Exchange
- LIMN NYSE
- CPAC Nasdaq
- Market Cap
- LIMN 623.8M
- CPAC 493.6M
- IPO Year
- LIMN N/A
- CPAC 2012
- Fundamental
- Price
- LIMN $16.60
- CPAC $5.99
- Analyst Decision
- LIMN
- CPAC Sell
- Analyst Count
- LIMN 0
- CPAC 2
- Target Price
- LIMN N/A
- CPAC $6.20
- AVG Volume (30 Days)
- LIMN 611.0K
- CPAC 3.1K
- Earning Date
- LIMN 01-01-0001
- CPAC 07-21-2025
- Dividend Yield
- LIMN N/A
- CPAC 8.37%
- EPS Growth
- LIMN N/A
- CPAC 15.59
- EPS
- LIMN N/A
- CPAC 0.13
- Revenue
- LIMN N/A
- CPAC $545,786,617.00
- Revenue This Year
- LIMN N/A
- CPAC N/A
- Revenue Next Year
- LIMN N/A
- CPAC N/A
- P/E Ratio
- LIMN N/A
- CPAC $9.21
- Revenue Growth
- LIMN N/A
- CPAC 2.78
- 52 Week Low
- LIMN $4.40
- CPAC $5.10
- 52 Week High
- LIMN $33.66
- CPAC $6.65
- Technical
- Relative Strength Index (RSI)
- LIMN N/A
- CPAC 59.73
- Support Level
- LIMN N/A
- CPAC $5.73
- Resistance Level
- LIMN N/A
- CPAC $6.00
- Average True Range (ATR)
- LIMN 0.00
- CPAC 0.11
- MACD
- LIMN 0.00
- CPAC -0.01
- Stochastic Oscillator
- LIMN 0.00
- CPAC 96.46
About LIMN LIMINATUS PHARMA INC
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.
About CPAC Cementos Pacasmayo S.A.A. (Each representing five)
Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.